✦ LIBER ✦

Platelet sparing effect of COX II inhibition used with pegylated interferon alfa-2a for the treatment of chronic hepatitis C: a short term pilot study

✍ Scribed by Magdalene M George; S.David Li; Ayse L Mindikoglu; Mehdi H Baluch; Sonu Dhillon; Deborah Farr; David H Van Thiel

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Detection of hepatocellular carcinoma du

✍ M. Capanni; E. Lorefice; M.C. Benini; M.R. Biagini; A. Tozzi; A. Galli; C. Surre 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 114 KB

[632] IMPACT OF TARIBAVIRIN EXPOSURE ON

✍ P. Pockros; M. Rodrigues-Torres; Y. Lurie; S. Gordon; M. Shiffman; Y. Li; B. Mur 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 147 KB

Daily or three times a week interferon a

✍ V. de Ledinghen; P. Trimoulet; M. Winnock; J. Foucher; G. Chene; P. Couzigou; P. 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 126 KB

Effects of pegylated interferon alfa-2b

✍ Steven I. Berk; Alain H. Litwin; Julia H. Arnsten; Evelyn Du; Irene Soloway; Mar 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 697 KB

PIN42 The Cost-Effectiveness of Telaprev

✍ Curtis, S.; Cure, S.; Bianic, F.; Gavart, S.; Dearden, L.; Fleischmann, J.; Ouwe 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

Association between the treatment length

✍ Norihiro Furusyo; Eiji Kajiwara; Kazuhiro Takahashi; Hideyuki Nomura; Yuichi Tan 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 329 KB